News

Cardiologist Marsha Certain, MD, was murdered Thursday, April 19, in an apparent murder-suicide. She was 69 years old.

Marsha Certain, MD, FACC, was an interventional cardiologist in Brunswick, Georgia, for nearly 40 years.

meat-3139641_960_720.jpg

The popular high-fat, low-carb diet is associated with multiple short-term benefits, but they appear to diminish over time. 

Arrow

AskBio, acquired by Bayer for more than $2 billion in 2020, is enrolling patients for a new clinical trial focused on the therapy's effectiveness in adult patients with non-ischemic cardiomyopathy and heart failure. 

Video of Alexander Fanaroff explaining the details of the BE ACTIVE trial that gamified fitness for cardiac patients. #ACC #ACC24 #ACC2024

Alexander Fanaroff, MD, said the late-breaking BE ACTIVE clinical trial presented at ACC.24 offers a blueprint for how to get patients to be more physically active.

Even patients who were never hospitalized for COVID-19 face a heightened risk of cardiovascular issues. #longcovid

Stroke is typically seen as the biggest danger for patients after they receive an AFib diagnosis. This study, however, suggests heart failure could be an even bigger threat.

TAVR JenaValve Trilogy Heart Valve System pure AR

The 65-year-old male patient presented with a long medical history and many comorbidities, making surgery too risky.

2024 has been a banner year for structural heart treatments, especially those focused on the tricuspid valve. In February, for example, Edwards Lifesciences made history when its Evoque transcatheter tricuspid valve replacement (TTVR) system became the first device of its kind to gain U.S. Food and Drug Administration (FDA) approval for treating tricuspid regurgitation (TR). Two months later, Abbott’s TriClip transcatheter edge-to-edge repair (TEER) system also gained FDA approval for the treatment of TR.

How have recent FDA approvals for Edwards Lifesciences and Abbott changed patient care? Andrew Rassi, MD, answered that question—and many more—in a new interview. 

the words "FDA recall" on a board

There have been a total of 11 incidents so far, including seven injuries and two deaths. Boston Scientific said the agent can still be used if operators follow specific instructions during lower GI bleed embolization procedures.  

New findings out of the University of Missouri suggests that the long-lasting impact of COVID-19 may not be quite as substantial as some researchers originally believed. The study’s authors evaluated nearly 50 different symptoms to see if they were more common up to one year after a person has been infected with COVID-19. They found, however, that this was true of just seven symptoms: heart palpitations, chest pain, shortness of breath, joint pain, hair loss, fatigue and obesity. #COVID19 #longCOVID

The analysis, presented at AHA Scientific Sessions 2021, included approximately 2,000 symptomatic COVID-19 patients who were not necessarily sick enough to be hospitalized. 

Even though automated external defibrillators are available in public places, most out-of-hospital cardiac arrests happen in the home.

 U.S. Senate has confirmed cardiologist Robert Califf as next FDA commissioner. 

The AHA believes the next FDA commissioner should play a key role in influencing public health post-COVID-19.

Cardiologist heart

The solution provides users with an interactive 3D map of the patient's heart.

Around the web

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Philips introduced a new CT system at ECR aimed at the rapidly growing cardiac CT market, incorporating numerous AI features to optimize workflow and image quality.